BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND AFP, AFPD, FETA, HPAFP
6620 results:

  • 1. Serum ApoB/ApoA1 ratio in patients with CHB and the occurrence of HBV related cirrhosis and HBV related hepatocellular carcinoma.
    Cai X; Peng S; Xiao X; Huang Z; Zhang P
    Sci Rep; 2024 May; 14(1):10996. PubMed ID: 38744926
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Development of a machine learning-based model to predict prognosis of alpha-fetoprotein-positive hepatocellular carcinoma.
    Dong B; Zhang H; Duan Y; Yao S; Chen Y; Zhang C
    J Transl Med; 2024 May; 22(1):455. PubMed ID: 38741163
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Lysyl oxidase-like 2 as a predictor of hepatocellular carcinoma in patients with hepatitis C virus after sustained virological response.
    Chida T; Ohta K; Noritake H; Matsushita M; Murohisa G; Kageyama F; Sasada Y; Oyaizu T; Tsugiki M; Tamakoshi K; Nakajima T; Suda T; Kawata K
    Sci Rep; 2024 May; 14(1):10864. PubMed ID: 38740815
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma.
    Golam RM; Khalil MAF; Shaker OG; Ahmed TI; Elguaad MKA; Hassan EA; El-Ansary MRM; Ismail A; Kandil YI; Mohammed OA; Doghish AS
    PLoS One; 2024; 19(5):e0303314. PubMed ID: 38739668
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. DGPRI, a new liver fibrosis assessment index, predicts recurrence of afp-negative hepatocellular carcinoma after hepatic resection: a single-center retrospective study.
    Zhang B; Xue J; Xu B; Chang J; Li X; Huang Z; Zhao H; Cai J
    Sci Rep; 2024 May; 14(1):10726. PubMed ID: 38730095
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Serum β-klotho is a potential biomarker for the progression of hepatitis B virus-related liver diseases.
    Miao X; Peng C; Yan F; Guo X; Xia L; Song Q; An X; Wu G
    J Infect Dev Ctries; 2024 Apr; 18(4):618-626. PubMed ID: 38728647
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Laparoscopic-assisted microwave ablation in treatment of small hepatocellular carcinoma: safety and efficacy in comparison with laparoscopic hepatectomy.
    Wei Y; Zhang L; Zhang S; Song M; Ji C
    BMC Surg; 2024 May; 24(1):138. PubMed ID: 38715071
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. GALAD score as a prognostic model for recurrence of hepatocellular carcinoma after local ablation.
    Qiao W; Li J; Xiong Y; Zheng J; Jin R; Hu C
    J Cancer Res Clin Oncol; 2024 May; 150(5):241. PubMed ID: 38713414
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma -CLEAP 004 study.
    Yang CX; Pan YX; Ye F; Zhu XD; Xue J; Li X; Yuan ZG; Zhang L; Xu L; Chen YJ; Wang NY; Sun HC; Liu XF;
    Front Immunol; 2024; 15():1310239. PubMed ID: 38711515
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Efficacy of microwave ablation with parallel acupuncture guided by ultrasound in treating single hepatocellular carcinoma in high-risk areas: A retrospective analysis of 155 patients.
    Liu S; Zhou P; Shen Q; Qian G
    J Cancer Res Ther; 2024 Apr; 20(2):547-554. PubMed ID: 38687924
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Evaluation of Circular RNA SMARCA5 as a Novel Biomarker for Hepatocellular Carcinoma.
    Bedair HM; El-Banna EA; Ahmed EA; Elhelbawy MG; Abdelfattah A; Khalaf FA; Abdel-Samiee M; El Sharnoby A
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1411-1417. PubMed ID: 38680002
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical Utility of Cytokeratins for Accurate Diagnosis of Hepatocellular Carcinoma Among Hepatitis C Virus High-Risk Patients.
    Al Haddad M; El-Mezayen HA; El-Kassas M; Metwally F; El-Sharkawy A
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1325-1332. PubMed ID: 38679993
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Structural characteristics of alpha-fetoprotein, including N-glycosylation, metal ion and fatty acid binding sites.
    Liu K; Wu C; Zhu M; Xu J; Lin B; Lin H; Liu Z; Li M
    Commun Biol; 2024 Apr; 7(1):505. PubMed ID: 38678117
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Current Roles of Ramucirumab in the Sequential Treatment of Unresectable Hepatocellular Carcinoma.
    Koizumi A; Komatsu S; Omiya S; Yano Y; Fujishima Y; Ishida J; Kido M; Gon H; Fukushima K; Urade T; So S; Yoshida T; Arai K; Fujinaka R; Shimura Y; Yanagimoto H; Toyama H; Ueda Y; Kodama Y; Fukumoto T
    Anticancer Res; 2024 May; 44(5):2055-2061. PubMed ID: 38677746
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Therapeutic Management and Outcomes of Hepatoblastoma in a Pediatric Patient with Mosaic Edwards Syndrome.
    Sosnowska-Sienkiewicz P; Kamińska A; Anderko I; Telman-Kołodziejczyk G; Mańkowski P; Januszkiewicz-Lewandowska D
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674397
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma.
    Zhu W; Zhang Z; Chen J; Chen X; Huang L; Zhang X; Huang X; Ma N; Xu W; Yi X; Lu X; Fu X; Li S; Mo G; Wang Y; Yuan G; Zang M; Li Q; Jiang X; He Y; Wu S; He Y; Li Y; Hou J
    Signal Transduct Target Ther; 2024 Apr; 9(1):101. PubMed ID: 38643203
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Fonction de l'ARNnc exosomal HEIH dans le carcinome hépatocellulaire associé au virus de l'hépatite B].
    Yu T; Li H; Shen G; Wu Q
    Ann Biol Clin (Paris); 2024 Apr; 82(1):93-102. PubMed ID: 38638022
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Long noncoding RNA small nucleolar RNA host genes as prognostic molecular biomarkers in hepatocellular carcinoma: A meta-analysis.
    Huang M; Zhao Z; Yang L
    Cancer Med; 2024 Apr; 13(8):e7200. PubMed ID: 38634194
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Alpha-fetoprotein: Past, present, and future.
    Yeo YH; Lee YT; Tseng HR; Zhu Y; You S; Agopian VG; Yang JD
    Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38619448
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Efficacy of radiofrequency ablation combined with sorafenib for treating liver cancer complicated with portal hypertension and prognostic factors.
    Yang LM; Wang HJ; Li SL; Gan GH; Deng WW; Chang YS; Zhang LF
    World J Gastroenterol; 2024 Mar; 30(11):1533-1544. PubMed ID: 38617449
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 331.